Description
Flibanserin
Flibanserin, also known as Addyi, is a medication approved for the treatment of pre-menopausal women with hypoactive sexual desire disorder (HSDD). It works by reducing the amount of 5-hydroxytryptamine which inhibits sexuality and improve dopamine levels that act as a sexual stimulant.
Flibanserin is known to directly effect the sexual pleasure control area of the female brain to aid in restoring deminishing female libido. By adjusting the aphrodisiac body system, it can help to restore the balance of sexual appetite suppression and exciting mechanism and as such lead to healthier sexual performance.
| Flibanserin | |
| CAS Number | 16793-07-05 |
| Molar Mass | 390.4g.mol |
| Chemical Formula | C20H21F3N4O |
| IUPAC Name | 3-[2-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]ethyl]-1H-benzimidazol-2-one |
IML Affiliate Disclosure
Some links on IML may connect readers with third-party suppliers through affiliate arrangements. IML may receive compensation from qualifying transactions at no additional cost to the reader, but the third-party supplier remains responsible for the actual sale, fulfillment, and product documentation.
